Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 1

Status

Unknown 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Colorectal Neoplasms 1295Pancreatic Neoplasms 819Carcinoma, Hepatocellular 782Stomach Neoplasms 754Rectal Neoplasms 565Esophageal Neoplasms 452Colonic Neoplasms 414Esophageal Squamous Cell Carcinoma 277Neoplasm Metastasis 263Cholangiocarcinoma 251Liver Neoplasms 219Neoplasms 200Biliary Tract Neoplasms 179Adenocarcinoma Of Esophagus 139Gastrointestinal Stromal Tumors 108Gallbladder Neoplasms 96Adenocarcinoma 94Breast Neoplasms 91Gastrointestinal Neoplasms 89Carcinoma, Non-Small-Cell Lung 87Bile Duct Neoplasms 69Sarcoma 67Lung Neoplasms 64Ovarian Neoplasms 60Anus Neoplasms 59Melanoma 54Uterine Cervical Neoplasms 52Carcinoma 48Digestive System Neoplasms 45Prostatic Neoplasms 40

Interventions

Oxaliplatin 2Capecitabine 2toripalimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Locally Advanced Colon Cancer × Gastrointestinal × Clear all
NCT05732493 2023-02-17

TORCH-C

Fudan University

Phase 2 Unknown
120 enrolled
Gastrointestinal

Locally Advanced Colon Cancer

NCT04389151 2020-05-15

Triplezumab Combined With CAPEOX Regimen in Neoadjuvant Therapy for Locally Advanced Colon Cancer

The First Affiliated Hospital of Xiamen University

Phase 2 Unknown
30 enrolled
Gastrointestinal

Locally Advanced Colon Cancer

NCT04188158 2019-12-05

ELECLA

Universidad de León

Phase 2 Unknown
238 enrolled
Gastrointestinal

Locally Advanced Colon Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡